Nu Skin Enterprises and Toyo Bio-Pharma Enter Agreement for Joint Product Research and Development

Nu Skin Enterprises and Toyo Bio-Pharma Enter Agreement for Joint Product Research and Development Nu Skin Enterprises, Inc. (NUS) has announced that it has has signed a memorandum of understanding for a joint research and development relationship with Toyo Bio-Pharma, Inc. (a subsidiary of Toyo Shinyaku, Japan), a natural products manufacturer with facilities in the United States and Japan. To facilitate this relationship, the companies established a new joint venture, NU Toyo Research, Inc., in the United States.
Home Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava Modern Science Confirms Ancient Wisdom! Modern Science Confirms Ancient Wisdom! "Natural" or "Plant-Derived" Labeling Can Mislead CDN: Natural Health Products Report - Update NPI Editorial: Are we using Best Practices? AHPA Update: Kava Information from the AHPA Executive Committee European Commission Proposes Registration Scheme for Herbal Medicine to Avoid Need for Testing Statement on Kava in New Zealand BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning BICL Discontinues Kava Sales; Health Canada Issues Consumer Warning Danisco A/S announces sale of Danisco Sugar A/S to Nordzucker AG Danisco A/S has announced that it has agreed to sell Danisco Sugar A/S to Nordzucker AG for an enterprise value of DKK 5,600 million. In addition, Danisco will receive DKK 600 million of cash proceeds from the sale of EU quota in 2007/08 and earlier Danisco A/S announces sale of Danisco Sugar A/S to Nordzucker AG Danisco A/S has announced that it has agreed to sell Danisco Sugar A/S to Nordzucker AG for an enterprise value of DKK 5,600 million. In addition, Danisco will receive DKK 600 million of cash proceeds from the sale of EU quota in 2007/08 and earlier Cargill breaks ground for specialty canola research and production centre in Aberdeen Cargill hosted a groundbreaking event June 26 at the Aberdeen, Saskatchewan site of the company’s future specialty canola research and production centre, scheduled to open in November 2008. Cargill breaks ground for specialty canola research and production centre in Aberdeen Cargill hosted a groundbreaking event June 26 at the Aberdeen, Saskatchewan site of the company’s future specialty canola research and production centre, scheduled to open in November 2008. Cargill breaks ground for specialty canola research and production centre in Aberdeen Cargill hosted a groundbreaking event June 26 at the Aberdeen, Saskatchewan site of the company’s future specialty canola research and production centre, scheduled to open in November 2008. Dynova Laboratories Brings OTC Healthcare Marketing Expertise To Natural Products Market Dynova Laboratories has announced the acquisition of SiCap Industries LLC and its innovative line of capsaicin-based products marketed under the Sinus Buster brand. Dynova Laboratories Brings OTC Healthcare Marketing Expertise To Natural Products Market Dynova Laboratories has announced the acquisition of SiCap Industries LLC and its innovative line of capsaicin-based products marketed under the Sinus Buster brand. Lonza Announces U.S. Authorized Distributors Lonza announces the appointment of Seltzer Ingredients and Pharmachem Laboratories, Inc. as Lonza’s authorized U.S. distributors for its nutritional ingredient, Carnipure(TM). Lonza Announces U.S. Authorized Distributors Lonza announces the appointment of Seltzer Ingredients and Pharmachem Laboratories, Inc. as Lonza’s authorized U.S. distributors for its nutritional ingredient, Carnipure(TM). Herbalife Receives Approval for Five Provincial Direct-Selling Licenses in China Herbalife Ltd. (HLF) has announced that China's Ministry of Commerce has granted five additional licenses for the company to conduct direct-selling business in the provinces of Beijing, Guangdong, Shandong, Zhejiang and Guizhou. All licenses are effective immediately, except Beijing which will be activated after the company opens service outlets. Herbalife Receives Approval for Five Provincial Direct-Selling Licenses in China Herbalife Ltd. (HLF) has announced that China's Ministry of Commerce has granted five additional licenses for the company to conduct direct-selling business in the provinces of Beijing, Guangdong, Shandong, Zhejiang and Guizhou. All licenses are effective immediately, except Beijing which will be activated after the company opens service outlets. ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit Compounds ChromaDex Corp., (OTCBB: CDXC) has announced that its wholly owned subsidiary has entered into a world-wide license agreement with The Research Foundation of the State University of New York, on behalf of the University at Buffalo (SUNY Buffalo), to produce and market three classes of plant-based ingredients for nutraceutical, functional food, beverage, natural chemical, cosmetic and pharmaceutical industries. ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit Compounds ChromaDex Corp., (OTCBB: CDXC) has announced that its wholly owned subsidiary has entered into a world-wide license agreement with The Research Foundation of the State University of New York, on behalf of the University at Buffalo (SUNY Buffalo), to produce and market three classes of plant-based ingredients for nutraceutical, functional food, beverage, natural chemical, cosmetic and pharmaceutical industries. ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit Compounds ChromaDex Corp., (OTCBB: CDXC) has announced that its wholly owned subsidiary has entered into a world-wide license agreement with The Research Foundation of the State University of New York, on behalf of the University at Buffalo (SUNY Buffalo), to produce and market three classes of plant-based ingredients for nutraceutical, functional food, beverage, natural chemical, cosmetic and pharmaceutical industries. ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit Compounds ChromaDex Corp., (OTCBB: CDXC) has announced that its wholly owned subsidiary has entered into a world-wide license agreement with The Research Foundation of the State University of New York, on behalf of the University at Buffalo (SUNY Buffalo), to produce and market three classes of plant-based ingredients for nutraceutical, functional food, beverage, natural chemical, cosmetic and pharmaceutical industries. ChromaDex Licenses Green Chemistry Technology to Manufacture a New Class of Super Fruit Compounds ChromaDex Corp., (OTCBB: CDXC) has announced that its wholly owned subsidiary has entered into a world-wide license agreement with The Research Foundation of the State University of New York, on behalf of the University at Buffalo (SUNY Buffalo), to produce and market three classes of plant-based ingredients for nutraceutical, functional food, beverage, natural chemical, cosmetic and pharmaceutical industries. Lyndhurst Naturals Acquires Rights to New Lines Lyndhurst Naturals has announced that it has been appointed broker in Western Canada for the following brands: The Bio-Vert(TM) range of environmentally friendly cleaning products and The equibar(TM) range of certified organic fruit bars. Lyndhurst Naturals Acquires Rights to New Lines Lyndhurst Naturals has announced that it has been appointed broker in Western Canada for the following brands: The Bio-Vert(TM) range of environmentally friendly cleaning products and The equibar(TM) range of certified organic fruit bars. Lyndhurst Naturals Acquires Rights to New Lines Lyndhurst Naturals has announced that it has been appointed broker in Western Canada for the following brands: The Bio-Vert(TM) range of environmentally friendly cleaning products and The equibar(TM) range of certified organic fruit bars. NBTY Reports Third Quarter Results NBTY, Inc. (NYSE: NTY) has announced FY08 Q3 results, reporting net sales of $535 million compared to $503 million for the fiscal third quarter prior year, with net income of $46 million, or $0.72 per diluted share, compared to $51 million, or $0.74 per diluted share, for the fiscal third quarter ended June 30, 2007. NBTY Reports Third Quarter Results NBTY, Inc. (NYSE: NTY) has announced FY08 Q3 results, reporting net sales of $535 million compared to $503 million for the fiscal third quarter prior year, with net income of $46 million, or $0.72 per diluted share, compared to $51 million, or $0.74 per diluted share, for the fiscal third quarter ended June 30, 2007. CRN Announces New Dues Structure For 2009 The Council for Responsible Nutrition (CRN) has announced a new membership dues structure for Voting members, effective January 2009, in an effort to make membership more accessible to mid-size and even smaller companies in the industry. CRN Announces New Dues Structure For 2009 The Council for Responsible Nutrition (CRN) has announced a new membership dues structure for Voting members, effective January 2009, in an effort to make membership more accessible to mid-size and even smaller companies in the industry. CRN Announces New Dues Structure For 2009 The Council for Responsible Nutrition (CRN) has announced a new membership dues structure for Voting members, effective January 2009, in an effort to make membership more accessible to mid-size and even smaller companies in the industry. CRN Announces New Dues Structure For 2009 The Council for Responsible Nutrition (CRN) has announced a new membership dues structure for Voting members, effective January 2009, in an effort to make membership more accessible to mid-size and even smaller companies in the industry. Comax Flavors Announces the Hiring of Dr. John L. Cavallo As Its New President Comax Flavors has announced the hiring of Dr. John L. Cavallo, formerly the Senior Vice President of Symrise’s Global Beverage Business Unit, as the new President of Comax. Comax Flavors Announces the Hiring of Dr. John L. Cavallo As Its New President Comax Flavors has announced the hiring of Dr. John L. Cavallo, formerly the Senior Vice President of Symrise’s Global Beverage Business Unit, as the new President of Comax. Comax Flavors Announces the Hiring of Dr. John L. Cavallo As Its New President Comax Flavors has announced the hiring of Dr. John L. Cavallo, formerly the Senior Vice President of Symrise’s Global Beverage Business Unit, as the new President of Comax. Comax Flavors Announces the Hiring of Dr. John L. Cavallo As Its New President Comax Flavors has announced the hiring of Dr. John L. Cavallo, formerly the Senior Vice President of Symrise’s Global Beverage Business Unit, as the new President of Comax. Cargill receives patent for breakthrough taste modification ID technology Cargill has announced that it has received a patent for a breakthrough technology in taste tissue imaging and taste modification that is superior to the cell screening technology currently available in the flavor, food and beverage industries. The patented technology will allow Cargill to effectively discover taste modifiers – such as sweetness enhancers, bitterness blockers, savory enhancers and salt enhancers – and develop flavors that make food and beverage products taste better. Cargill receives patent for breakthrough taste modification ID technology Cargill has announced that it has received a patent for a breakthrough technology in taste tissue imaging and taste modification that is superior to the cell screening technology currently available in the flavor, food and beverage industries. The patented technology will allow Cargill to effectively discover taste modifiers – such as sweetness enhancers, bitterness blockers, savory enhancers and salt enhancers – and develop flavors that make food and beverage products taste better. Cargill receives patent for breakthrough taste modification ID technology Cargill has announced that it has received a patent for a breakthrough technology in taste tissue imaging and taste modification that is superior to the cell screening technology currently available in the flavor, food and beverage industries. The patented technology will allow Cargill to effectively discover taste modifiers – such as sweetness enhancers, bitterness blockers, savory enhancers and salt enhancers – and develop flavors that make food and beverage products taste better. Silliker Announces Proprietary Testing Method Licensing Agreement with Kraft Foods Silliker has announced a licensing agreement with Kraft Foods for a patent pending in vitro method for predicting the Glycemic Index (GI) of foods. Silliker Announces Proprietary Testing Method Licensing Agreement with Kraft Foods Silliker has announced a licensing agreement with Kraft Foods for a patent pending in vitro method for predicting the Glycemic Index (GI) of foods. Silliker Announces Proprietary Testing Method Licensing Agreement with Kraft Foods Silliker has announced a licensing agreement with Kraft Foods for a patent pending in vitro method for predicting the Glycemic Index (GI) of foods. SunOpta Announces First Quarter 2008 Results SunOpta Inc. (STKL) (CA:SOY) has announced FY08 Q1 results, reporting revenues of $230,444,000 as compared to $183,500,000 in the first quarter of 2007, with earnings of $1,486,000 or $0.02 per diluted common share as compared to 2007 first quarter earnings of $1,055,000 or $0.02 per diluted common share. SunOpta Announces First Quarter 2008 Results SunOpta Inc. (STKL) (CA:SOY) has announced FY08 Q1 results, reporting revenues of $230,444,000 as compared to $183,500,000 in the first quarter of 2007, with earnings of $1,486,000 or $0.02 per diluted common share as compared to 2007 first quarter earnings of $1,055,000 or $0.02 per diluted common share. SunOpta Announces First Quarter 2008 Results SunOpta Inc. (STKL) (CA:SOY) has announced FY08 Q1 results, reporting revenues of $230,444,000 as compared to $183,500,000 in the first quarter of 2007, with earnings of $1,486,000 or $0.02 per diluted common share as compared to 2007 first quarter earnings of $1,055,000 or $0.02 per diluted common share. Greg Horn Named Solbar North American Business Director Solbar Industries Ltd. has announced the appointment of Greg Horn to direct the company's business, marketing and sales activities in North America (U.S. and Canada), beginning August 1st, 2008, to be responsible for implementing Solbar's business marketing plan focused on specialty soy proteins including isolates, functional and textured soy concentrates and Solbar's Bontex steam-textured soy proteins. Greg Horn Named Solbar North American Business Director Solbar Industries Ltd. has announced the appointment of Greg Horn to direct the company's business, marketing and sales activities in North America (U.S. and Canada), beginning August 1st, 2008, to be responsible for implementing Solbar's business marketing plan focused on specialty soy proteins including isolates, functional and textured soy concentrates and Solbar's Bontex steam-textured soy proteins. Greg Horn Named Solbar North American Business Director Solbar Industries Ltd. has announced the appointment of Greg Horn to direct the company's business, marketing and sales activities in North America (U.S. and Canada), beginning August 1st, 2008, to be responsible for implementing Solbar's business marketing plan focused on specialty soy proteins including isolates, functional and textured soy concentrates and Solbar's Bontex steam-textured soy proteins. Greg Horn Named Solbar North American Business Director Solbar Industries Ltd. has announced the appointment of Greg Horn to direct the company's business, marketing and sales activities in North America (U.S. and Canada), beginning August 1st, 2008, to be responsible for implementing Solbar's business marketing plan focused on specialty soy proteins including isolates, functional and textured soy concentrates and Solbar's Bontex steam-textured soy proteins. Reliv International Reports Second-Quarter Results; Restructures European Operations Reliv International, Inc. (RELV) has announced FY08 Q12 results, reporting net sales of $24.0 million, compared to net sales of $26.3 million in the second quarter last year, with net income of $569,000 or $0.04 per diluted share, compared to net income of $823,000 or $0.05 per diluted share in the second quarter of 2007. Reliv International Reports Second-Quarter Results; Restructures European Operations Reliv International, Inc. (RELV) has announced FY08 Q12 results, reporting net sales of $24.0 million, compared to net sales of $26.3 million in the second quarter last year, with net income of $569,000 or $0.04 per diluted share, compared to net income of $823,000 or $0.05 per diluted share in the second quarter of 2007. Nu Skin Enterprises Reports Second-Quarter 2008 Results Nu Skin Enterprises, Inc. (NUS) has announced FY08 Q2 results, reporting revenue of $321.7 million, a 12 percent improvement over the prior-year period, with earnings per share of $0.32 compared to $0.21 for the same quarter of 2007. Nu Skin Enterprises Reports Second-Quarter 2008 Results Nu Skin Enterprises, Inc. (NUS) has announced FY08 Q2 results, reporting revenue of $321.7 million, a 12 percent improvement over the prior-year period, with earnings per share of $0.32 compared to $0.21 for the same quarter of 2007. Nutraceutical Reports Q3 Results Nutraceutical International Corporation (NUTR) has announced FY08 Q3 results, reporting net sales of $40.5 million compared to $38.7 million for the same quarter prior year, with net income of $2.9 million, or $0.26 diluted earnings per share, compared to net income of $2.9 million, or $0.25 diluted earnings per share, for the same quarter of fiscal 2007. Nutraceutical Reports Q3 Results Nutraceutical International Corporation (NUTR) has announced FY08 Q3 results, reporting net sales of $40.5 million compared to $38.7 million for the same quarter prior year, with net income of $2.9 million, or $0.26 diluted earnings per share, compared to net income of $2.9 million, or $0.25 diluted earnings per share, for the same quarter of fiscal 2007. Balchem Corporation Announces 2nd Quarter 2008 Results Balchem Corporation (BCPC) has announced FY08 Q2 results, reporting net sales of $62.9 million compared to $44.4 million prior year, with net earnings of $4.7 million, an increase of $0.7 million, or 16.2% as compared with the same period last year. Sales of the Food, Pharma and Nutrition segment were $9.5 million, an increase of 19.6% from the prior year comparable quarter. Balchem Corporation Announces 2nd Quarter 2008 Results Balchem Corporation (BCPC) has announced FY08 Q2 results, reporting net sales of $62.9 million compared to $44.4 million prior year, with net earnings of $4.7 million, an increase of $0.7 million, or 16.2% as compared with the same period last year. Sales of the Food, Pharma and Nutrition segment were $9.5 million, an increase of 19.6% from the prior year comparable quarter. PacificHealth Laboratories Reports Second Quarter 2008 Results PacificHealth Laboratories, Inc. (PHLI) has announced Fy08 Q2 results, reporting revenues of $2,370,429 compared to $2,069,889 for the same period in 2007, with a net loss of ($146,608), or ($0.01) per share compared to a net loss of ($127,276), or ($0.01) per share, for the same period in 2007. PacificHealth Laboratories Reports Second Quarter 2008 Results PacificHealth Laboratories, Inc. (PHLI) has announced Fy08 Q2 results, reporting revenues of $2,370,429 compared to $2,069,889 for the same period in 2007, with a net loss of ($146,608), or ($0.01) per share compared to a net loss of ($127,276), or ($0.01) per share, for the same period in 2007. Fenchem Maintains Competitive Vitamin E price The price of Fenchem’s TOCOVET® natural source vitamin E in North America is being maintained within the marketplace, due to large stocks and expanding production. Fenchem Maintains Competitive Vitamin E price The price of Fenchem’s TOCOVET® natural source vitamin E in North America is being maintained within the marketplace, due to large stocks and expanding production. Aquapharm and Croda International Sign Three Year Research Collaboration Agreement Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement in which Croda will have an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care. Aquapharm and Croda International Sign Three Year Research Collaboration Agreement Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement in which Croda will have an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care. Aquapharm and Croda International Sign Three Year Research Collaboration Agreement Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement in which Croda will have an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care. Aquapharm and Croda International Sign Three Year Research Collaboration Agreement Marine biotechnology company Aquapharm Biodiscovery Ltd and Croda International Plc today announced the signing of a collaboration and license agreement in which Croda will have an exclusive license to novel marine derived natural products identified through the collaboration from strains from Aquapharm’s proprietary microbial library for use in topical cosmetic applications in skin and hair care. DNP Notches 8% Second Quarter Increase DNP International has reported an eight percent second quarter increase compared to last year during the same time. DNP Notches 8% Second Quarter Increase DNP International has reported an eight percent second quarter increase compared to last year during the same time. Natural Alternatives International, Inc. Announces Sale of 'As We Change(R)' Assets and Provides Fourth Quarter Revenue Update Natural Alternatives International, Inc. (NAII) has announced that it has sold the "As We Change(R)" catalog and internet business of Real Health Laboratories, Inc., its wholly owned subsidiary, for $2.0 million subject to certain adjustments. Natural Alternatives International, Inc. Announces Sale of 'As We Change(R)' Assets and Provides Fourth Quarter Revenue Update Natural Alternatives International, Inc. (NAII) has announced that it has sold the "As We Change(R)" catalog and internet business of Real Health Laboratories, Inc., its wholly owned subsidiary, for $2.0 million subject to certain adjustments. Whole Foods Market reports third quarter results Whole Foods Market, Inc. has announced FY Q3 results reporting sales of approximately $1.8 billion with comparable store sales increased 2.6% Net income was approximately $33.9 million, and diluted earnings per share were $0.24 Whole Foods Market reports third quarter results Whole Foods Market, Inc. has announced FY Q3 results reporting sales of approximately $1.8 billion with comparable store sales increased 2.6% Net income was approximately $33.9 million, and diluted earnings per share were $0.24 Herbalife announces record Q2 results Herbalife Ltd. (HLF) has announced FY08 Q2 results, reporting net sales of $639.7 million, an increase of 20.7 percent compared to the same period of 2007, with net income of $67.1 million, or $1.01 per diluted share, compared to $48.1 million, or $0.65 per diluted share in the second quarter of 2007. Herbalife announces record Q2 results Herbalife Ltd. (HLF) has announced FY08 Q2 results, reporting net sales of $639.7 million, an increase of 20.7 percent compared to the same period of 2007, with net income of $67.1 million, or $1.01 per diluted share, compared to $48.1 million, or $0.65 per diluted share in the second quarter of 2007. Jamba, Inc. Announces Changes to Its Senior Management Team Jamba, Inc. (JMBA) has announced that Steven R. Berrard, the Company's Chairman of the Board, has assumed the role of interim Chief Executive Officer and President of the Company, replacing Paul E. Clayton, and Karen Luey, Vice President, Controller, and Principal Accounting Officer of the Company, has assumed the role of interim Chief Financial Officer of the Company, replacing Donald D. Breen. Jamba, Inc. Announces Changes to Its Senior Management Team Jamba, Inc. (JMBA) has announced that Steven R. Berrard, the Company's Chairman of the Board, has assumed the role of interim Chief Executive Officer and President of the Company, replacing Paul E. Clayton, and Karen Luey, Vice President, Controller, and Principal Accounting Officer of the Company, has assumed the role of interim Chief Financial Officer of the Company, replacing Donald D. Breen. Jamba, Inc. Announces Changes to Its Senior Management Team Jamba, Inc. (JMBA) has announced that Steven R. Berrard, the Company's Chairman of the Board, has assumed the role of interim Chief Executive Officer and President of the Company, replacing Paul E. Clayton, and Karen Luey, Vice President, Controller, and Principal Accounting Officer of the Company, has assumed the role of interim Chief Financial Officer of the Company, replacing Donald D. Breen. Jamba, Inc. Announces Changes to Its Senior Management Team Jamba, Inc. (JMBA) has announced that Steven R. Berrard, the Company's Chairman of the Board, has assumed the role of interim Chief Executive Officer and President of the Company, replacing Paul E. Clayton, and Karen Luey, Vice President, Controller, and Principal Accounting Officer of the Company, has assumed the role of interim Chief Financial Officer of the Company, replacing Donald D. Breen. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	PROVO, Utah, July 28, 2008 /PRNewswire-FirstCall via COMTEX/ -- Nu Skin Enterprises, Inc. (NUS) today announced that the company has signed a memorandum of understanding for a joint research and development relationship with Toyo Bio-Pharma, Inc. (a subsidiary of Toyo Shinyaku, Japan), a natural products manufacturer with facilities in the United States and Japan. To facilitate this relationship, the companies established a new joint venture, NU Toyo Research, Inc., in the United States. Nu Skin Enterprises is the first direct selling company to have such an agreement with Toyo Bio-Pharma. The companies' collaborative development efforts will focus on sharing scientific and regulatory insights, as well as developing proprietary nutraceutical and cosmeceutical products for Nu Skin sales through its worldwide distribution network. "We expect this relationship with Nu Skin Enterprises to nicely complement our current expertise in natural health supplements," said Yoshi Shiraishi, president and chief operating officer of Toyo Bio-Pharma. "We highly respect the industry-leading research and development capabilities of Nu Skin Enterprises. We believe there is a synergy between the two research teams that both companies can benefit from." "Toyo Bio-Pharma is a subsidiary of Toyo Shinyaku, which is one of the most reputable supplement and skin care manufacturers in Japan, and we look forward to developing a robust relationship with joint development opportunities," said Joseph Chang, Ph. D., chief scientific officer and executive vice president of product development at Nu Skin Enterprises. "We are eager to leverage their knowledge of navigating regulatory requirements for skin care and supplements in Japan." About Toyo Bio-Pharma Toyo Bio-Pharma(TM) ( http://www.toyobiopharma.com) is a subsidiary of Toyo Shinyaku Co., Ltd., a research-driven manufacturer committed to providing consumers and clients with high-value ingredients derived from nature. With the most advanced instrumentation, continuous research and commitment to quality and integrity, Toyo Shinyaku is pioneering the use of fermentation and culturing to produce beneficial, effective products for use in the nutraceutical, functional food and cosmeceuticals industries. Toyo Shinyaku is Japan's largest developer of FOSHU (Food for Specialized Health Use) products and ODM (Original Design Manufacturer) of supplement and skin care products. Toyo Shinyaku follows rigorous standards of ISO 9001:2000 and ISO 22000:2005, and was one of the first Japanese companies to become Food and Drug Administration (FDA) Good Manufacturing Practices (GMP)-compliant for food products and dietary supplements. About Nu Skin Enterprises Nu Skin Enterprises, Inc. is a global direct selling company operating in 47 markets throughout Asia, the Americas and Europe. The company markets premium-quality personal care products under the Nu Skin(R) brand, science-based nutritional supplements under the Pharmanex(R) brand, and technology-based products and services under the Big Planet(R) brand. Nu Skin Enterprises is traded on the New York Stock Exchange under the symbol "NUS." More information is available at http://www.nuskinenterprises.com.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software